BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3293049)

  • 1. T24 human bladder carcinoma cells with activated Ha-ras protooncogene: nontumorigenic cells susceptible to malignant transformation with carcinogen.
    Senger DR; Perruzzi CA; Ali IU
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5107-11. PubMed ID: 3293049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.
    Geiser AG; Der CJ; Marshall CJ; Stanbridge EJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5209-13. PubMed ID: 3523486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenicity of T24 urinary bladder carcinoma cell sublines.
    Flatow U; Rabson AB; Rabson AS
    Int J Cancer; 1987 Aug; 40(2):240-5. PubMed ID: 3301693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive overexpression of a 89 kDa heat shock protein gene in the HBL100 human mammary cell line converted to a tumorigenic phenotype by the EJ/T24 Harvey-ras oncogene.
    Lebeau J; Le Chalony C; Prosperi MT; Goubin G
    Oncogene; 1991 Jul; 6(7):1125-32. PubMed ID: 1861862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene.
    Hurlin PJ; Maher VM; McCormick JJ
    Proc Natl Acad Sci U S A; 1989 Jan; 86(1):187-91. PubMed ID: 2643097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC.
    Milo GE; Shuler C; Kurian P; French BT; Mannix DG; Noyes I; Hollering J; Sital N; Schuller D; Trewyn RW
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1268-72. PubMed ID: 2406716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
    Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
    Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense-fos RNA causes partial reversion of the transformed phenotypes induced by the c-Ha-ras oncogene.
    Ledwith BJ; Manam S; Kraynak AR; Nichols WW; Bradley MO
    Mol Cell Biol; 1990 Apr; 10(4):1545-55. PubMed ID: 1690847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-induced modulation of human ras oncogene expression.
    Samid D; Schaff Z; Chang EH; Friedman RM
    Prog Clin Biol Res; 1985; 192():265-8. PubMed ID: 2417251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype.
    Lee H; Li D; Prior T; Casto BC; Weghorst CM; Shuler CF; Milo GE
    Cell Biol Toxicol; 1997 Oct; 13(6):419-34. PubMed ID: 9352120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes.
    Bradley MO; Kraynak AR; Storer RD; Gibbs JB
    Proc Natl Acad Sci U S A; 1986 Jul; 83(14):5277-81. PubMed ID: 3523488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the neoplastic phenotype of EBV-established B lymphocytes by the human Ha-ras oncogene.
    Nasi S; Sirinian MI; Panetta G; Marchetti A; Jucker R
    Oncogene; 1990 Jan; 5(1):117-22. PubMed ID: 2157177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and phenotypic changes associated with the acquisition of tumorigenicity in human bladder cancer.
    Gildea JJ; Golden WL; Harding MA; Theodorescu D
    Genes Chromosomes Cancer; 2000 Mar; 27(3):252-63. PubMed ID: 10679914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a c-met proto-oncogene activated in human xeroderma pigmentosum cells after treatment with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
    Michelin S; Daya-Grosjean L; Sureau F; Saïd S; Sarasin A; Suárez HG
    Oncogene; 1993 Jul; 8(7):1983-91. PubMed ID: 8510940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effects of malignant phenotype of human bladder cancer cell line by c-Ha-ras, c-myc antisense oligodeoxynucleotide].
    Li M; Yu M; Jin F
    Zhonghua Wai Ke Za Zhi; 1996 Jan; 34(1):7-9. PubMed ID: 9275677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.